Aiping Tong

Sichuan University — China

Medicine · Health Sciences

44h-index7.8kcitations225works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(41), RNA Interference and Gene Delivery(25), Virus-based gene therapy research(21), Monoclonal and Polyclonal Antibodies Research(21), Immunotherapy and Immune Responses(18)

Publications225 total

From Lock‐and‐Key to Velcro: Glycan‐Dependent T Cell Recruiter Redefines Cancer Cell Targeting With Density‐Dependent Recognition
MedComm·2026Open Access
YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma
Journal for ImmunoTherapy of Cancer·2026Open Access
CCR2 knockdown attenuates post-hemorrhagic hydrocephalus and improves glymphatic function after intraventricular hemorrhage
Experimental Neurology·2026
Tumor-targeting oncolytic HSV-SUR15 enhances anti-tumor immunity in glioblastoma
International Immunopharmacology·2025Open Access
Nose‐to‐Brain Delivery of <i>Chlorella vulgaris</i> Extracellular Vesicles for Antidepressant Effects
Journal of Extracellular Vesicles·2025Open Access
Structure-guided design of potent tetrazolo[1,5-a]pyrimidine-based tubulin inhibitors with in vivo antitumor activity
European Journal of Medicinal Chemistry·2025
A chimeric oncolytic adenovirus carried by macrophages for glioma immunotherapy
Biochemical and Biophysical Research Communications·2025· 1 cited
Black phosphorus nanosheets boost mitochondrial oxidative phosphorylation improving immunotherapy outcomes
Nature Nanotechnology·2025· 4 cited
A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity
Cell Reports Medicine·2025Open Access
Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation
Acta Pharmaceutica Sinica B·2025Open Access
High fructose consumption aggravates inflammation by promoting effector T cell generation via inducing metabolic reprogramming
Signal Transduction and Targeted Therapy·2025· 7 citedOpen Access
Enhancing anti-tumor immunity and reducing toxicity: A medicine and food homology formula for ICB therapy
Cell Biomaterials·2025· 1 citedOpen Access
CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia
Chinese Medical Journal·2025· 2 citedOpen Access
Corrigendum to “Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N.Tanaka aqueous extracts” [J. Ethnopharmacol. 350 (2025) 120024]
Journal of Ethnopharmacology·2025
Tumor immunotherapy: past, present, and future
International Journal of Surgery·2025· 2 citedOpen Access
Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion
Science Advances·2025· 10 citedOpen Access
A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytes
International Immunopharmacology·2025
Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors
Journal for ImmunoTherapy of Cancer·2025· 5 citedOpen Access
Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N. Tanaka aqueous extracts
Journal of Ethnopharmacology·2025
Inhibition of histone deacetylase 6 activity mitigates neurological impairment and post-hemorrhagic hydrocephalus after intraventricular hemorrhage by modulating pyroptosis and autophagy pathways
Fluids and Barriers of the CNS·2025· 2 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Gang Guo(21), Liangxue Zhou(17), Yuelong Wang(14), Xin Tang(12), Zongliang Zhang(11), Yuquan Wei(9), Jianhan Huang(9), Kunhong Zhong(8), Jianguo Xu(8), Meijun Zheng(8), Shasha Zhao(7), Mei Lan(7), Min Mu(6), Canhua Huang(6), Rangrang Fan(6), Xiangrong Song(5), Chunlai Nie(5), Bo Han(5), Minghai Tang(5), Wei Wang(4)